Clinical Trials Browser

Phase 2 × exemestane × Other neoplasm × Clear all

NCT02025712 2014-01-01

Exemestane Plus Everolimus for Hormone-receptor Positive Metastatic Breast Cancer

Phase 2 Unknown

BreastOther neoplasm

Hormone Receptor Positive Malignant Neoplasm of Breast